GlassScriptPhysician profile
Andre Johnathan Kennedy
NPI 1962900357
$9,262.34
in general payments reported to CMS, 2019-2025
41 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,507 · 2022: $2,231 · 2023: $2,306 · 2024: $1,740 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,520 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,519.63 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,174.65 | 2021-2025 | Speedicath, Porges Coloplast, Titan |
| Janssen Biotech, INC. | $982.28 | 2021-2025 | Erleada, Akeega |
| Medtronic, INC. | $836.49 | 2021-2025 | Interstim |
| Antares Pharma, INC. | $590.97 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $541.58 | 2021-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $538.66 | 2022-2025 | |
| Accord Healthcare, INC. | $514.14 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $366.07 | 2021-2023 | Prolaris |
| Sumitomo Pharma America, INC. | $321.44 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $292.00 | 2022-2025 | |
| Urogen Pharma, INC. | $285.92 | 2022-2025 | Jelmyto |
| Tolmar, INC. | $280.44 | 2023-2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $260.88 | 2021-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $227.88 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $217.01 | 2021-2025 | Urolift |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.